{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T23:33:51Z","timestamp":1783467231413,"version":"3.55.0"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2015,1,31]],"date-time":"2015-01-31T00:00:00Z","timestamp":1422662400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"published-print":{"date-parts":[[2015,12]]},"DOI":"10.1186\/s12879-015-0755-9","type":"journal-article","created":{"date-parts":[[2015,1,30]],"date-time":"2015-01-30T17:08:44Z","timestamp":1422637724000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":29,"title":["Antimicrobial susceptibility\/resistance and NG-MAST characterisation of Neisseria gonorrhoeae in Belarus, Eastern Europe, 2010\u20132013"],"prefix":"10.1186","volume":"15","author":[{"given":"Fiodar","family":"Lebedzeu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Golparian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leonid","family":"Titov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nataliya","family":"Pankratava","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Slavyana","family":"Glazkova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irina","family":"Shimanskaya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natallia","family":"Charniakova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aliaksandr","family":"Lukyanau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marius","family":"Domeika","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Magnus","family":"Unemo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,1,31]]},"reference":[{"key":"755_CR1","volume-title":"Sexually Transmitted Infections in Europe 2012","author":"European Centre for Disease Prevention and Control","year":"2014","unstructured":"European Centre for Disease Prevention and Control. Sexually Transmitted Infections in Europe 2012. Stockholm: ECDC; 2014. Available at: http:\/\/www.ecdc.europa.eu\/en\/publications\/Publications\/sexually-transmitted-infections-europe-surveillance-report-2012.pdf (Accessed: December 17, 2014)."},{"issue":"Suppl 4","key":"755_CR2","doi-asserted-by":"publisher","first-page":"iv42","DOI":"10.1136\/sextrans-2012-050909","volume":"89","author":"M Unemo","year":"2013","unstructured":"Unemo M, Ison CA, Cole M, Spiteri G, van de Laar M, Khotenashvili L. Gonorrhoea and gonococcal antimicrobial resistance surveillance networks in the WHO European Region, including the independent countries of the former Soviet Union. Sex Transm Infect. 2013;89 Suppl 4:iv42\u20136.","journal-title":"Sex Transm Infect"},{"key":"755_CR3","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1136\/sti.2010.042317","volume":"86","author":"M Unemo","year":"2010","unstructured":"Unemo M, Shipitsyna E, Domeika M. Recommended antimicrobial treatment of uncomplicated gonorrhoea in 2009 in 11 East European countries: implementation of a Neisseria gonorrhoeae antimicrobial susceptibility programme in this region is crucial. Sex Transm Infect. 2010;86:442\u20134.","journal-title":"Sex Transm Infect"},{"key":"755_CR4","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1111\/j.1600-0463.2011.02780.x","volume":"119","author":"M Unemo","year":"2011","unstructured":"Unemo M, Shipitsyna E, Domeika M. Gonorrhoea surveillance, laboratory diagnosis and antimicrobial susceptibility testing of Neisseria gonorrhoeae in 11 countries of the eastern part of the WHO European region. APMIS. 2011;119:643\u20139.","journal-title":"APMIS"},{"key":"755_CR5","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1128\/CMR.00010-14","volume":"27","author":"M Unemo","year":"2014","unstructured":"Unemo M, Shafer WM. Antimicrobial resistance in Neisseria gonorrhoeae in the 21st Century: past, evolution, and future. Clin Microbiol Rev. 2014;27:587\u2013613.","journal-title":"Clin Microbiol Rev"},{"key":"755_CR6","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1586\/eri.09.63","volume":"7","author":"JW Tapsall","year":"2009","unstructured":"Tapsall JW, Ndowa F, Lewis DA, Unemo M. Meeting the public health challenge of multidrug- and extensively drug-resistant Neisseria gonorrhoeae. Expert Rev Anti Infect Ther. 2009;7:821\u201334.","journal-title":"Expert Rev Anti Infect Ther"},{"key":"755_CR7","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1136\/sti.2010.042648","volume":"86","author":"DA Lewis","year":"2010","unstructured":"Lewis DA. The gonococcus fights back: is this time a knock out? Sex Transm Infect. 2010;86:415\u201321.","journal-title":"Sex Transm Infect"},{"key":"755_CR8","doi-asserted-by":"publisher","first-page":"1401","DOI":"10.2217\/fmb.12.117","volume":"7","author":"M Unemo","year":"2012","unstructured":"Unemo M, Nicholas RA. Emergence of multi-drug resistant, extensively drug-resistant and untreatable gonorrhea. Future Microbiol. 2012;7:1401\u201322.","journal-title":"Future Microbiol"},{"key":"755_CR9","doi-asserted-by":"publisher","first-page":"2059","DOI":"10.1093\/jac\/dks188","volume":"67","author":"DM Whiley","year":"2012","unstructured":"Whiley DM, Goire N, Lahra MM, Donovan B, Limnios AE, Nissen MD, et al. The ticking time bomb: escalating antibiotic resistance in Neisseria gonorrhoeae is a public health disaster in waiting. J Antimicrob Chemother. 2012;67:2059\u201361.","journal-title":"J Antimicrob Chemother"},{"key":"755_CR10","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1056\/NEJMp1112456","volume":"366","author":"GA Bolan","year":"2012","unstructured":"Bolan GA, Sparling PF, Wasserheit JN. The emerging threat of untreatable gonococcal infection. N Engl J Med. 2012;366:485\u20137.","journal-title":"N Engl J Med"},{"issue":"Suppl 4","key":"755_CR11","doi-asserted-by":"publisher","first-page":"iv16","DOI":"10.1136\/sextrans-2013-051117","volume":"89","author":"G Spiteri","year":"2013","unstructured":"Spiteri G, Cole M, Unemo M, Hoffmann S, Ison C, van de Laar M. The European Gonococcal Antimicrobial Surveillance Programme (Euro-GASP)--a sentinel approach in the European Union (EU)\/European Economic Area (EEA). Sex Transm Infect. 2013;89 Suppl 4:iv16\u20138.","journal-title":"Sex Transm Infect"},{"key":"755_CR12","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1099\/jmm.0.007641-0","volume":"58","author":"J Tapsall","year":"2009","unstructured":"Tapsall J, Read P, Carmody C, Bourne C, Ray S, Limnios A, et al. Two cases of failed ceftriaxone treatment in pharyngeal gonorrhoea verified by molecular microbiological methods. J Med Microbiol. 2009;58:683\u20137.","journal-title":"J Med Microbiol"},{"issue":"6","key":"755_CR13","doi-asserted-by":"crossref","first-page":"19792","DOI":"10.2807\/ese.16.06.19792-en","volume":"16","author":"M Unemo","year":"2011","unstructured":"Unemo M, Golparian D, Hestner A. Ceftriaxone treatment failure of pharyngeal gonorrhoea verified by international recommendations, Sweden, July 2010. Euro Surveill. 2011;16(6):19792.","journal-title":"Euro Surveill"},{"issue":"25","key":"755_CR14","doi-asserted-by":"crossref","first-page":"20200","DOI":"10.2807\/ese.17.25.20200-en","volume":"17","author":"M Unemo","year":"2012","unstructured":"Unemo M, Golparian D, Potocnik M, Jeverica S. Treatment failure of pharyngeal gonorrhoea with internationally recommended first-line ceftriaxone verified in Slovenia, September 2011. Euro Surveill. 2012;17(25):20200.","journal-title":"Euro Surveill"},{"key":"755_CR15","doi-asserted-by":"publisher","first-page":"3538","DOI":"10.1128\/AAC.00325-11","volume":"55","author":"M Ohnishi","year":"2011","unstructured":"Ohnishi M, Golparian D, Shimuta K, Saika T, Hoshina S, Iwasaku K, et al. Is Neisseria gonorrhoeae initiating a future era of untreatable gonorrhea?: detailed characterization of the first strain with high-level resistance to ceftriaxone. Antimicrob Agents Chemother. 2011;55:3538\u201345.","journal-title":"Antimicrob Agents Chemother"},{"key":"755_CR16","doi-asserted-by":"publisher","first-page":"1445","DOI":"10.1093\/jac\/dkt017","volume":"68","author":"YM Chen","year":"2013","unstructured":"Chen YM, Stevens K, Tideman R, Zaia A, Tomita T, Fairley CK, et al. Failure of ceftriaxone 500\u00a0mg to eradicate pharyngeal gonorrhoea, Australia. J Antimicrob Chemother. 2013;68:1445\u20137.","journal-title":"J Antimicrob Chemother"},{"key":"755_CR17","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1071\/SH13077","volume":"10","author":"PJ Read","year":"2013","unstructured":"Read PJ, Limnios EA, McNulty A, Whiley D, Lahra LM. One confirmed and one suspected case of pharyngeal gonorrhoea treatment failure following 500\u00a0mg ceftriaxone in Sydney, Australia. Sex Health. 2013;10:460\u20132.","journal-title":"Sex Health"},{"issue":"30","key":"755_CR18","doi-asserted-by":"publisher","first-page":"pii:20862","DOI":"10.2807\/1560-7917.ES2014.19.30.20862","volume":"19","author":"D Golparian","year":"2014","unstructured":"Golparian D, Ohlsson A, Janson H, Lidbrink P, Richtner T, Ekelund O, et al. Four treatment failures of pharyngeal gonorrhoea with ceftriaxone (500 mg) or cefotaxime (500 mg), Sweden, 2013 and 2014. Euro Surveill. 2014;19(30):pii:20862.","journal-title":"Euro Surveill"},{"key":"755_CR19","first-page":"1","volume-title":"Global action plan to control the spread and impact of antimicrobial resistance in Neisseria gonorrhoeae","author":"World Health Organization (WHO), Department of Reproductive Health and Research","year":"2012","unstructured":"World Health Organization (WHO), Department of Reproductive Health and Research. Global action plan to control the spread and impact of antimicrobial resistance in Neisseria gonorrhoeae. Geneva: WHO; 2012. p. 1\u201336. Available at: http:\/\/www.who.int\/reproductivehealth\/publications\/rtis\/9789241503501 (Accessed: December 17, 2014)."},{"key":"755_CR20","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1136\/sextrans-2012-050674","volume":"88","author":"F Ndowa","year":"2012","unstructured":"Ndowa F, Lusti-Narasimhan M, Unemo M. The serious threat of multidrug-resistant and untreatable gonorrhoea: the pressing need for global action to control the spread of antimicrobial resistance, and mitigate the impact on sexual and reproductive health. Sex Transm Infect. 2012;88:317\u20138.","journal-title":"Sex Transm Infect"},{"key":"755_CR21","first-page":"1","volume-title":"Response plan to control and manage the threat of multidrug-resistant gonorrhoea in Europe","author":"European Centre for Disease Prevention and Control (ECDC)","year":"2012","unstructured":"European Centre for Disease Prevention and Control (ECDC). Response plan to control and manage the threat of multidrug-resistant gonorrhoea in Europe. Stockholm: ECDC; 2012. p. 1\u201323. Available at: http:\/\/www.ecdc.europa.eu\/en\/publications\/Publications\/1206-ECDC-MDR-gonorrhoea-response-plan.pdf (Accessed: December 17, 2014)."},{"key":"755_CR22","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1258\/ijsa.2009.009051","volume":"20","author":"M Domeika","year":"2009","unstructured":"Domeika M, Savicheva A, Sokolovskiy E, Ballard R, Unemo M, Eastern European Network for Sexual and Reproductive Health (EE SRH Network). Quality enhancements and quality assurance of laboratory diagnosis of sexually transmitted infections in Eastern Europe. Int J STD AIDS. 2009;20:365\u20137.","journal-title":"Int J STD AIDS"},{"key":"755_CR23","doi-asserted-by":"publisher","first-page":"1142","DOI":"10.1093\/jac\/dkp098","volume":"63","author":"M Unemo","year":"2009","unstructured":"Unemo M, Fasth O, Fredlund H, Limnios A, Tapsall JW. Phenotypic and genetic characterization of the 2008 WHO Neisseria gonorrhoeae reference strain panel intended for global quality assurance and quality control of gonococcal antimicrobial resistance surveillance for public health purposes. J Antimicrob Chemother. 2009;63:1142\u201351.","journal-title":"J Antimicrob Chemother"},{"key":"755_CR24","first-page":"249","volume":"14","author":"JW Tapsall","year":"1981","unstructured":"Tapsall JW, Cheng JK. Rapid identification of pathogenic species of Neisseria by carbohydrate degradation tests: importance of glucose in media used for preparation of inocula. Br J Ven Dis. 1981;14:249\u201352.","journal-title":"Br J Ven Dis"},{"key":"755_CR25","doi-asserted-by":"publisher","first-page":"1497","DOI":"10.1086\/383047","volume":"189","author":"IM Martin","year":"2004","unstructured":"Martin IM, Ison CA, Aanensen DM, Fenton KA, Spratt BG. Rapid sequence-based identification of gonococcal transmission clusters in a large metropolitan area. J Infect Dis. 2004;189:1497\u2013505.","journal-title":"J Infect Dis"},{"key":"755_CR26","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1128\/CMR.00040-10","volume":"24","author":"M Unemo","year":"2011","unstructured":"Unemo M, Dillon JA. Review and international recommendation of methods for typing Neisseria gonorrhoeae isolates and their implications for improved knowledge of gonococcal epidemiology, treatment, and biology. Clin Microbiol Rev. 2011;24:447\u201358.","journal-title":"Clin Microbiol Rev"},{"key":"755_CR27","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1111\/j.1600-0463.2007.apm_487.x","volume":"115","author":"M Unemo","year":"2007","unstructured":"Unemo M, Sj\u00f6strand A, Akhras M, Gharizadeh B, Lindb\u00e4ck E, Pourmand N, et al. Molecular characterization of Neisseria gonorrhoeae identifies transmission and resistance of one ciprofloxacin-resistant strain. APMIS. 2007;115:231\u201341.","journal-title":"APMIS"},{"key":"755_CR28","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1111\/j.1600-0463.2011.02770.x","volume":"119","author":"S Glazkova","year":"2011","unstructured":"Glazkova S, Golparian D, Titov L, Pankratova N, Suhabokava N, Shimanskaya I, et al. Antimicrobial susceptibility\/resistance and molecular epidemiological characteristics of Neisseria gonorrhoeae in 2009 in Belarus. APMIS. 2011;119:537\u201342.","journal-title":"APMIS"},{"key":"755_CR29","unstructured":"Ministry of Health in Belarus: Annex 2 to the Order of Health Ministry of October 29, 2009 \u2116 1020 \u201cClinical diagnosis and treatment protocol of patients with sexually transmitted infections\u201d. [In Russian]"},{"key":"755_CR30","doi-asserted-by":"publisher","first-page":"873","DOI":"10.1111\/j.1469-0691.2007.01764.x","volume":"13","author":"M Unemo","year":"2007","unstructured":"Unemo M, Vorobieva V, Firsova N, Ababkova T, Leniv I, Haldorsen BC, et al. The Neisseria gonorrhoeae population transmitted in Arkhangelsk, Russia in 2004 \u2013 phenotypic and genotypic heterogeneity. Clin Microbiol Infect. 2007;13:873\u20138.","journal-title":"Clin Microbiol Infect"},{"key":"755_CR31","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1136\/sti.2007.029033","volume":"84","author":"A Kubanova","year":"2008","unstructured":"Kubanova A, Kubanov A, Frigo N, Sidorenko S, Priputnevich T, Vachnina T, et al. National surveillance of antimicrobial susceptibility in Neisseria gonorrhoeae in 2005\u20132006 and recommendations of first-line antimicrobial drugs for gonorrhoea treatment in Russia. Sex Transm Infect. 2008;84:285\u20139.","journal-title":"Sex Transm Infect"},{"issue":"14","key":"755_CR32","doi-asserted-by":"crossref","first-page":"19533","DOI":"10.2807\/ese.15.14.19533-en","volume":"15","author":"A Kubanova","year":"2010","unstructured":"Kubanova A, Frigo N, Kubanov A, Sidorenko S, Lesnaya I, Polevshikova S, et al. The Russian gonococcal antimicrobial susceptibility programme (RU-GASP) \u2013 national resistance prevalence in 2007 and 2008, and trends during 2005\u20132008. Euro Surveill. 2010;15(14):19533.","journal-title":"Euro Surveill"},{"issue":"1","key":"755_CR33","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1186\/1471-2334-14-342","volume":"14","author":"A Kubanova","year":"2014","unstructured":"Kubanova A, Kubanov A, Frigo N, Solomka V, Semina V, Vorobyev D, et al. Russian gonococcal antimicrobial susceptibility programme (RU-GASP) - resistance in Neisseria gonorrhoeae during 2009\u20132012 and NG-MAST genotypes in 2011 and 2012. BMC Infect Dis. 2014;14(1):342.","journal-title":"BMC Infect Dis"},{"key":"755_CR34","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1093\/jac\/dkn235","volume":"62","author":"HM Palmer","year":"2008","unstructured":"Palmer HM, Young H, Winter A, Dave J. Emergence and spread of azithromycin-resistant Neisseria gonorrhoeae in Scotland. J Antimicrob Chemother. 2008;62:490\u20134.","journal-title":"J Antimicrob Chemother"},{"key":"755_CR35","doi-asserted-by":"publisher","first-page":"3812","DOI":"10.1128\/AAC.00309-10","volume":"54","author":"SA Chisholm","year":"2012","unstructured":"Chisholm SA, Dave J, Ison CA. High-level azithromycin resistance occurs in Neisseria gonorrhoeae as a result of a single point mutation in the 23S rRNA genes. Antimicrob Agents Chemother. 2012;54:3812\u20136.","journal-title":"Antimicrob Agents Chemother"},{"key":"755_CR36","doi-asserted-by":"publisher","first-page":"1200","DOI":"10.1093\/jac\/dkp118","volume":"63","author":"S Starnino","year":"2009","unstructured":"Starnino S, Stefanelli P, Neisseria gonorrhoeae Italian Study Group I. Azithromycin-resistant Neisseria gonorrhoeae strains recently isolated in Italy. J Antimicrob Chemother. 2009;63:1200\u20134.","journal-title":"J Antimicrob Chemother"},{"key":"755_CR37","doi-asserted-by":"publisher","first-page":"1652","DOI":"10.1128\/AAC.01506-09","volume":"54","author":"PG Galarza","year":"2010","unstructured":"Galarza PG, Abad R, Canigia LF, Buscemi L, Pagano I, Oviedo C, et al. New mutation in 23S rRNA gene associated with high level of azithromycin resistance in Neisseria gonorrhoeae. Antimicrob Agents Chemother. 2010;54:1652\u20133.","journal-title":"Antimicrob Agents Chemother"},{"key":"755_CR38","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1093\/cid\/cir929","volume":"54","author":"AR Katz","year":"2012","unstructured":"Katz AR, Komeya AY, Soge OO, Kiaha MI, Lee MV, Wasserman GM, et al. Neisseria gonorrhoeae with high-level resistance to azithromycin: case report of the first isolate identified in the United States. Clin Infect Dis. 2012;54:841\u20133.","journal-title":"Clin Infect Dis"},{"key":"755_CR39","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1128\/AAC.02093-13","volume":"58","author":"M Unemo","year":"2013","unstructured":"Unemo M, Golparian D, Hellmark B. First three Neisseria gonorrhoeae isolates with high-level resistance to azithromycin in Sweden: a threat to currently available dual-antimicrobial regimens for treatment of gonorrhea? Antimicrob Agents Chemother. 2013;58:624\u20135.","journal-title":"Antimicrob Agents Chemother"},{"key":"755_CR40","doi-asserted-by":"publisher","first-page":"1517","DOI":"10.1093\/jac\/dku026","volume":"69","author":"S Jeverica","year":"2014","unstructured":"Jeverica S, Golparian D, Maticic M, Poto\u010dnik M, Mlakar B, Unemo M. Phenotypic and molecular characterization of Neisseria gonorrhoeae isolates from Slovenia, 2006\u201312: rise and fall of the multidrug-resistant NG-MAST genogroup 1407 clone? J Antimicrob Chemother. 2014;69:1517\u201325.","journal-title":"J Antimicrob Chemother"},{"issue":"1","key":"755_CR41","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1186\/1471-2334-14-65","volume":"14","author":"B Mlynarczyk-Bonikowska","year":"2014","unstructured":"Mlynarczyk-Bonikowska B, Serwin AB, Golparian D, Walter de Walthoffen S, Majewski S, Koper M, et al. Antimicrobial susceptibility\/resistance and genetic characteristics of Neisseria gonorrhoeae isolates from Poland, 2010\u20132012. BMC Infect Dis. 2014;14(1):65.","journal-title":"BMC Infect Dis"},{"key":"755_CR42","doi-asserted-by":"publisher","first-page":"762","DOI":"10.1016\/S1473-3099(13)70143-9","volume":"13","author":"CA Ison","year":"2013","unstructured":"Ison CA, Town K, Obi C, Chisholm S, Hughes G, Livermore DM, et al. Decreased susceptibility to cephalosporins among gonococci: data from the Gonococcal Resistance to Antimicrobials Surveillance Programme (GRASP) in England and Wales, 2007\u20132011. Lancet Infect Dis. 2013;13:762\u20138.","journal-title":"Lancet Infect Dis"},{"issue":"3","key":"755_CR43","doi-asserted-by":"crossref","first-page":"20358","DOI":"10.2807\/ese.18.03.20358-en","volume":"18","author":"SA Chisholm","year":"2013","unstructured":"Chisholm SA, Unemo M, Quaye N, Johansson E, Cole MJ, Ison CA, et al. Molecular epidemiological typing within the European gonococcal antimicrobial resistance surveillance programme reveals predominance of a multidrug-resistant clone. Euro Surveill. 2013;18(3):20358.","journal-title":"Euro Surveill"},{"key":"755_CR44","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1016\/S1473-3099(13)70693-5","volume":"14","author":"YH Grad","year":"2014","unstructured":"Grad YH, Kirkcaldy RD, Trees D, Dordel J, Harris SR, Goldstein E, et al. Genomic epidemiology of Neisseria gonorrhoeae with reduced susceptibility to cefixime in the USA: a retrospective observational study. Lancet Infect Dis. 2014;14:220\u20136.","journal-title":"Lancet Infect Dis"},{"issue":"Suppl 4","key":"755_CR45","doi-asserted-by":"publisher","first-page":"iv28","DOI":"10.1136\/sextrans-2012-050904","volume":"89","author":"M Bala","year":"2013","unstructured":"Bala M, Kakran M, Singh V, Sood S, Ramesh V. Monitoring antimicrobial resistance in Neisseria gonorrhoeae in selected countries of the WHO South-East Asia Region between 2009 and 2012: a retrospective analysis. Sex Transm Infect. 2013;89 Suppl 4:iv28\u201335.","journal-title":"Sex Transm Infect"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12879-015-0755-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-015-0755-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-015-0755-9","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-015-0755-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,2]],"date-time":"2021-09-02T07:46:51Z","timestamp":1630568811000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/s12879-015-0755-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,1,31]]},"references-count":45,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,12]]}},"alternative-id":["755"],"URL":"https:\/\/doi.org\/10.1186\/s12879-015-0755-9","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,1,31]]},"assertion":[{"value":"15 October 2014","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 January 2015","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 January 2015","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"29"}}